In this week’s episode, Avril is joined by Claudette Medefindt and Karen Denton from Retina South Africa. Claudette is Head of Science at Retina South Africa and an active member of Retina South Africa for over 40 years, as well as Deputy President of Retina International. Karen is Retina South Africa’s Age-related Macular Degeneration (AMD) Ambassador, and offers a wealth of experience in patient counselling and education.
Together, Claudette and Karen discuss the impact of the COVID-19 pandemic in South Africa and the rising concern among people receiving essential anti-VEGF treatment in these uncertain times.
Additionally, Claudette and Karen offer an insight into Retina South Africa’s research activity, particularly the genetic profiling of the indigenous population with respect to IRD’s and the remarkable progress they have made, explaining how they have achieved a genetic result for 60% of participants and contributing to clinical trials.
Listen to the full audio-recording of the podcast here:
In-Focus episode 2: Claudette Medefindt and Karen Denton
